← Evidence map

ReviewDrug design, development and therapy2020

The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults.

Omer Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

48 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32606598